Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in
  • Log out

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in
  • Log out

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Case ReportBrain

Ipilimumab-Induced Hypophysitis: MR Imaging Findings

K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber and F.R. Murtagh
American Journal of Neuroradiology October 2009, 30 (9) 1751-1753; DOI: https://doi.org/10.3174/ajnr.A1623
K.J. Carpenter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R.D. Murtagh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Lilienfeld
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Weber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F.R. Murtagh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

SUMMARY: Ipilimumab is a promising new immunotherapeutic antineoplastic agent with clinical activity in the treatment of metastatic melanoma and renal cell carcinoma. With advances in immunotherapy, however, a host of new side effects related to the mechanism of action of these drugs has appeared. At our institution, 3 patients presented with hypophysitis, which was attributed to an autoimmune process based on the documented relationship of the drug to other autoimmune phenomena and significant and rapid improvement with discontinuation of the drug and addition of steroids. We present the imaging findings in 3 patients with presumed ipilimumab-induced hypophysitis.

  • Copyright © American Society of Neuroradiology
View Full Text
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 30 (9)
American Journal of Neuroradiology
Vol. 30, Issue 9
1 Oct 2009
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber, F.R. Murtagh
American Journal of Neuroradiology Oct 2009, 30 (9) 1751-1753; DOI: 10.3174/ajnr.A1623

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Ipilimumab-Induced Hypophysitis: MR Imaging Findings
K.J. Carpenter, R.D. Murtagh, H. Lilienfeld, J. Weber, F.R. Murtagh
American Journal of Neuroradiology Oct 2009, 30 (9) 1751-1753; DOI: 10.3174/ajnr.A1623
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Case Reports
    • Discussion
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis
  • Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy
  • Ipilimumab Therapy for Melanoma: A Mimic of Leptomeningeal Metastases
  • Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
  • ENDOCRINE SIDE-EFFECTS OF ANTI-CANCER DRUGS: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses
  • Neurological immune-related adverse events of ipilimumab
  • Ipilimumab and Its Toxicities: A Multidisciplinary Approach
  • MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
  • Crossref (84)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
    Anne Bertrand, Marie Kostine, Thomas Barnetche, Marie-Elise Truchetet, Thierry Schaeverbeke
    BMC Medicine 2015 13 1
  • Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies
    David J. Byun, Jedd D. Wolchok, Lynne M. Rosenberg, Monica Girotra
    Nature Reviews Endocrinology 2017 13 4
  • Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
    Salvatore Maria Corsello, Agnese Barnabei, Paolo Marchetti, Liana De Vecchis, Roberto Salvatori, Francesco Torino
    The Journal of Clinical Endocrinology & Metabolism 2013 98 4
  • Ipilimumab and Its Toxicities: A Multidisciplinary Approach
    Leslie A. Fecher, Sanjiv S. Agarwala, F. Stephen Hodi, Jeffrey S. Weber
    The Oncologist 2013 18 6
  • Radiologic Manifestations of Immune-Related Adverse Events in Patients With Metastatic Melanoma Undergoing Anti–CTLA-4 Antibody Therapy
    Yulia Bronstein, Chaan S. Ng, Patrick Hwu, Wen-Jen Hwu
    American Journal of Roentgenology 2011 197 6
  • Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
    Frédérique Albarel, Caroline Gaudy, Frédéric Castinetti, Tiphaine Carré, Isabelle Morange, Bernard Conte-Devolx, Jean-Jacques Grob, Thierry Brue
    European Journal of Endocrinology 2015 172 2
  • Imaging of Cancer Immunotherapy: Current Approaches and Future Directions
    Mizuki Nishino, Hiroto Hatabu, F. Stephen Hodi
    Radiology 2019 290 1
  • Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
    Ahmad Tarhini
    Scientifica 2013 2013
  • MECHANISMS IN ENDOCRINOLOGY: Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review
    A. Juszczak, A. Gupta, N. Karavitaki, M. R. Middleton, A. B. Grossman
    European Journal of Endocrinology 2012 167 1
  • Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
    Meng H. Tan, Ravi Iyengar, Kara Mizokami-Stout, Sarah Yentz, Mark P. MacEachern, Li Yan Shen, Bruce Redman, Roma Gianchandani
    Clinical Diabetes and Endocrinology 2019 5 1

More in this TOC Section

  • Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis
  • Progression of Microstructural Damage in Spinocerebellar Ataxia Type 2: A Longitudinal DTI Study
  • SWI or T2*: Which MRI Sequence to Use in the Detection of Cerebral Microbleeds? The Karolinska Imaging Dementia Study
Show more BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire